Important RCTs in paediatric IBD during the last two decades, summarized in the current guidelines, concern the dosing and administration of anti-TNF and show the effectiveness of anti-TNF therapy in paediatric IBD (Table 2). This evidence concerns the gene TNF and inflammatory bowel disease.